Translational funging for Dr Hellenbrand and Prof. Driscoll for technology de-risking

Dr Hellenbrand and Prof. Driscoll were awarded translational funding from the Cambridge Enterprise Technology Investment Fund to take their technology, demonstrated in the lab, closer to commercialisation. The funding is for nearly two years and will help to de-risk the technology, which was demonstrated in the lab. At the end, the aim is to develop a minimum viable demonstrator to attract investor funding for a startup. This is an exciting opportunity for NeuCam!